Product Information
METHYLPHENIDATE 5 MG/5 ML SOLN is a generic product labeled by Eywa Pharma Inc, priced at $0.0782 per ML under NDC 71930002452. Its NADAC has been published 383 times since Jun 5, 2019.
FDA first approved this application on Oct 3, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Eywa Pharma IncNDC
71930002452
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210139FDA Approved
10/3/2018
TE Code
AA
On Market Since
3/29/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG/5 ML SOLN has been published 383 times since Jun 5, 2019, and over the history we have for it it has declined 42.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0782 per ML |
|---|---|
| All-time high | $0.1710 (May 11, 2022) |
| All-time low | $0.0642 (May 20, 2020) |
| 52-week high | $0.0827 |
| 52-week low | $0.0744 |
| Median price | $0.1014 |
| Average price | $0.1024 |
| Largest weekly change | +53.1% (Mar 23, 2022) |
| Weeks tracked | 383 |
| Tracking since | Jun 5, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eywa Pharma Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG/5 ML SOLN, manufactured by Eywa Pharma Inc, is $0.0782 per ML (NDC 71930002452), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 5 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG/5 ML SOLN has declined 42.3%. It has been tracked across 383 weekly CMS publications since Jun 5, 2019.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG/5 ML SOLN?
Since Jun 5, 2019, the NADAC for METHYLPHENIDATE 5 MG/5 ML SOLN has ranged from a low of $0.0642 (May 20, 2020) to a high of $0.1710 (May 11, 2022), with a median of $0.1014 per ML.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG/5 ML SOLN?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 5 MG/5 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 5 MG/5 ML SOLN?
METHYLPHENIDATE 5 MG/5 ML SOLN (NDC 71930002452) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.